Search Results - "Letendre, Louis"

Prognostic Factors and Outcomes of Adults With Hemophagocytic Lymphohistiocytosis by Parikh, Sameer A., MBBS, Kapoor, Prashant, MD, Letendre, Louis, MD, Kumar, Shaji, MD, Wolanskyj, Alexandra P., MD

“…Abstract Objective To describe the prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis (HLH), a rare disorder caused by…”
Get full text

Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia by Gangat, Naseema, Bleeker, Jonathan, Lynch, Douglas, Olteanu, Horatiu, Letendre, Louis, Tefferi, Ayalew

Get full text

Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin combination therapies by Abidi, Maheen Z., Sohail, Muhammad R., Cummins, Nathan, Wilhelm, Mark, Wengenack, Nancy, Brumble, Lisa, Shah, Harshal, Jane Hata, Donna, McCullough, Ann, Wendel, Amy, Vikram, Holenarasipur R., Kusne, Shimon, Litzow, Mark, Letendre, Louis, Lahr, Brian D., Poeschla, Eric, Walker, Randall C.

“…Summary As invasive mucormycosis (IM) numbers rise, clinicians suspect prior voriconazole worsens IM incidence and severity, and believe combination…”
Get full text

Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival by Elliott, Michelle A., Litzow, Mark R., Letendre, Louis L., Wolf, Robert C., Hanson, Curtis A., Tefferi, Ayalew, Tallman, Martin S.

“…In childhood acute lymphoblastic leukemia (ALL), a rapid decline of circulating leukemic blasts in response to induction chemotherapy or prednisone is one of…”
Get full text

Mitoxantrone, Etoposide, and Cytarabine With or Without Valspodar in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome: A Phase III Trial (E2995) by GREENBERG, Peter L, LEE, Sandra J, PAIETTA, Elisabeth, BENNETT, John M, ROWE, Jacob M, ADVANI, Ranjana, TALLMAN, Martin S, SIKIC, Branimir I, LETENDRE, Louis, DUGAN, Kathleen, LUM, Bert, CHIN, David L, DEWALD, Gordon

“…To determine whether adding the multidrug resistance gene-1 (MDR-1) modulator valspodar (PSC 833; Novartis Pharmaceuticals, Hanover, NJ) to chemotherapy…”
Get full text

Primary Myelodysplastic Syndromes by Gangat, Naseema, MBBS, Patnaik, Mrinal M., MBBS, Begna, Kebede, MD, Kourelis, Taxiarchis, MD, Al-Kali, Aref, MD, Elliott, Michelle A., MD, Hogan, William J., MD, Letendre, Louis, MD, Litzow, Mark R., MD, Knudson, Ryan A., BS, Ketterling, Rhett P., MD, Hodnefield, Janice M., MS, MT (ASCP), Hanson, Curtis A., MD, Pardanani, Animesh D., MBBS, PhD, Tefferi, Ayalew, MD

“…Abstract Objectives To share our 25 years of experience with patients with primary myelodysplastic syndromes (MDS) and to describe the natural history of the…”
Get full text

Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy by Elliott, Michelle A., Letendre, Louis, Tefferi, Ayalew, Hogan, William J., Hook, Christopher, Kaufmann, Scott H., Pruthi, Rajiv K., Pardanani, Animesh, Begna, Kebede H., Ashrani, Aneel A., Wolanskyj, Alexandra P., Al-Kali, Aref, Litzow, Mark R.

“…Therapy‐related acute promyelocytic leukemia (t‐APL) is a well‐recognized form of APL for which the underlying etiology has been well characterized. The…”
Get full text

Thromboembolism in Adults with Acute Lymphoblastic Leukemia During Induction with L-Asparaginase-containing Multi-agent Regimens: Incidence, Risk Factors, and Possible Role of Antithrombin by Elliott, Michelle A, Wolf, Robert C, Hook, Christopher C, Pruthi, Rajiv K, Heit, John A, Letendre, Louis L, Tefferi, Ayalew, Kaufmann, Scott H, Mesa, Ruben A, Litzow, Mark R

“…Thromboembolism (TE) is a known complication of L-asparaginase (ASP) therapy of acute lymphoblastic leukemia (ALL), possibly attributable to reduced synthesis…”
Get full text

Nilotinib treatment‐associated peripheral artery disease and sudden death: Yet another reason to stick to imatinib as front‐line therapy for chronic myelogenous leukemia by Tefferi, Ayalew, Letendre, Louis

Get full text

Isolated granulocytic sarcoma presenting as a brachial plexopathy by Mauermann, Michelle L., Angius, Diana, Spinner, Robert J., Letendre, Louis J., Amrami, Kimberly K., Dyck, P. James B.

Get full text

Going beyond 7 + 3 regimens in the treatment of adult acute myeloid leukemia by Tefferi, Ayalew, Letendre, Louis

Get full text

Phase I and Pharmacologic Study of Infusional Topotecan and Carboplatin in Relapsed and Refractory Acute Leukemia by KAUFMANN, Scott H, KARP, Judith E, LITZOW, Mark R, SLOAN, Jeff A, REID, Joel M, AMES, Matthew M, ADJEI, Alex A, ERLICHMAN, Charles, LETENDRE, Louis, KOTTKE, Timothy J, SAFGREN, Stephanie, GREER, Jackie, GOJO, Ivana, ATHERTON, Pamela, SVINGEN, Phyllis A, LOEGERING, David A

“…Purpose: To assess the maximum tolerated dose, toxicities, pharmacokinetics, and antileukemic activity of topotecan and carboplatin in adults with recurrent or…”
Get full text

Hemorrhagic polyneuropathy in idiopathic thrombocytopenic purpura by Moon, Joon-Shik, Dyck, P. James B., Engelstad, JaNean K., Witt, Lawrence V., Dyck, Peter J., Letendre, Louis

Get full text

Outcome of recipients of bone marrow transplants who require intensive-care unit support by Afessa, B, Tefferi, A, Hoagland, H C, Letendre, L, Peters, S G

“…To determine the outcome and prognostic factors associated with bone marrow transplantation (BMT), we reviewed the clinical course of 35 adult recipients of…”
Get more information

All‐trans‐retinoic acid‐induced myositis: A description of two patients by van der Vliet, Hans J.J., Roberson, Arthur E., Hogan, Marie C., Morales, Carlos E., Crader, Scott C., Letendre, Louis, Pruthi, Rajiv K.

“…All‐trans‐retinoic acid (ATRA) induces complete clinical remissions in a high proportion of patients with acute promyelocytic leukemia and has become the…”
Get full text

Acute leukemia in pregnancy: a single institution experience with 23 patients by Farhadfar, Nosha, Cerquozzi, Sonia, Hessenauer, Michael R., Litzow, Mark R., Hogan, William J., Letendre, Louis, Patnaik, Mrinal M., Tefferi, Ayalew, Gangat, Naseema

“…Management of acute leukemia during pregnancy presents a considerable challenge. Herein, we review our experience of 23 patients diagnosed with acute leukemia;…”
Get full text

Acute leukemia in pregnancy: A single institution experience by Farhadfar, Nosha, Cerquozzi, Sonia, Michael, Hessenauer R., Letendre, Louis, Hogan, William J., Litzow, Mark Robert, Patnaik, Mrinal M., Tefferi, Ayalew, Gangat, Naseema

“…Abstract only…”
Get full text

Safety and feasibility of lower antithrombin replacement targets in adult patients with hematological malignancies receiving asparaginase therapy by Barreto, Jason N., McCullough, Kristen B., Peskey, Candy S., Dierkhising, Ross A., Mara, Kristin C., Elliott, Michelle A., Gastineau, Dennis A., Al-Kali, Aref, Gangat, Naseema, Letendre, Louis, Hogan, William J., Litzow, Mark R., Patnaik, Mrinal M.

“…The optimal antithrombin(AT) activity parameters for replacement as thromboprophylaxis following asparaginase remains unclear. This single-center,…”
Get full text

Primary Myelodysplastic Syndromes: The Mayo Clinic Experience With 1000 Patients by Gangat, Naseema, Patnaik, Mrinal M, Begna, Kebede, Kourelis, Taxiarchis, Al-Kali, Aref, Elliott, Michelle A, Hogan, William J, Letendre, Louis, Litzow, Mark R, Knudson, Ryan A, Ketterling, Rhett P, Hodnefield, Janice M, Hanson, Curtis A, Pardanani, Animesh D, Tefferi, Ayalew

“…To share our 25 years of experience with patients with primary myelodysplastic syndromes (MDS) and to describe the natural history of the disease including…”
Get full text

Drug therapy for myelodysplastic syndrome by Tefferi, Ayalew, Letendre, Louis

“…Myelodysplastic syndrome (MDS) is currently a consensus‐based pathologic diagnosis that is determined by partly subjective findings on bone marrow histology…”
Get full text